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Abstract
In urine of diabetics, a significantly great inhibitory activity of glyceraldehyde 3-phosphate
dehydrogenase (GAP-Dehyd) was observed compared with that of normal subjects. The 0.2 ml of
urine from 41 patients with diabetes mellitus inhibited 0.5 units of GAP-Dehyd by 27.2 +/- 3.0%
(mean +/- S.E.M.), while that from 17 normal volunteers inhibited only by 9.0 +/- 1.0% (P less than
0.05). This inhibitory substance was extracted by 90% ethanol from diabetic urine and partially
purified by anion exchange chromatography using Dowex-1 (HCOO type). The molecular weight
of this substance was confirmed to be 100–300 daltons by an analysis on Biogel P-4 gel filtration
chromatography. And analysis by thin layer chromatography using silicagel plate showed that this
inhibitor was a ninhydrin reactive substance which has not been reported previously. From the
above facts, it was assumed that the inhibitory substance of GAP-Dehyd in urine of diabetics was
a new acidic compound of low molecular weight containing an amino residue in the molecule.
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Abstract. In urine of diabetics, a significantly great inhibitory activ-
ity of glyceraldehyde 3-phosphate dehydrogenase (GAP-Dehyd) was
observed compared with that of normal subjects. The 0.2 ml of urine
from 41 patients with diabetes mellitus inhibited 0.5 units of GAP-Dehyd
by 27.2±3.0% (mean±S.E. M.), while that from 17 normal volunteers
inhibited only by 9.0 ± 1.0% (P<0.05). This inhibitory substance was
extracted by 90% ethanol from diabetic urine and partially purified by
anion exchange chromatography using Dowex-l (HCOO type). The
molecular weight of this substance was confirmed to be 100-300 daltons
by an analysis on Biogel P-4 gel filtration chromatography. And analy-
sis by thin layer chromatography using silicagel plate showed that this
inhibitor was a ninhydrin reactive substance which has not been re-
ported previously. From the above facts, it was assumed that the in-
hibitory substance of GAP-Dehyd in urine of diabetics was a new acidic
compound of low molecular weight containing an amino residue in
the molecule.
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It was reported that an inhibitory substance(s) of glyceraldehyde 3-phos-
phate dehydrogenase (GAP-Dehyd) was present in plasma of diabetics (1,2).
But the chemical identification of this substance has not been performed yet, and
its originating organ and role in abnormal carbohydrate metabolism in diabetes
mellitus are not fully understood at present.
Bornstein and his co-workers reported that this inhibitory substance was a
polypeptide derived from the pituitary gland (3, 4), i.e. a peptide fragment of
growth hormone (5). However, Schwartz and Turfus (2) have recently showed
that a nonpeptide inhibitory substance of GAP-Dehyd with lower molecular
weight was present in plasma of diabetics, and the peptide of growth hormone
was not detected.
In an attempt to verify the presence of an inhibitory substance of GAP-
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Dehyd in diabetes mellitus, the inhibitory activity of unne of diabetics was
assayed.
MATERIALS AND METHODS
Urine samples. Urine samples were collected at 9-12 a.m. from 41 patients
(aged 20-67) with diabetes mellitus who visited and were hospitalized at Okayama
University Hospital. The samples were stored at -20°C until use. Control urine
samples were collected at 10-11 a.m. from 17 normal volunteers (aged 20-47).
Most of the subjects were not fasted.
Reagents. Crystalline rabbit muscle GAP-Dehyd (EC. 1. 2. 1. 12), ,9-NAD and
D-glyceraldehyde 3-phosphate (GAP) were purchased from Sigma Chemical Co.,
Ltd., U.S.A.. Ninhydrin solution was purchased from Tokyo Kasei Co., Ltd., and
petroleum pitch charcoal with a spherical granule (BAC-LQ) was supplied by
Kureha Kagaku Co., Ltd., Tokyo.
Assay of inhibitory activity of GAP-Dehyd. The assay of inhibitory activity of
GAP-Dehyd in urine was performed according to the method of Schwartz and
Turfus (2). The reaction mixture contained: 2.50 ml of 0.1 M pyrophosphate
buffer containing 0.02 M EDTA, pH 8.45; 0.10 ml of 1.02 X 10-2 M p-NAD; 0.10
ml of GAP-Dehyd solution (5 units/ml); and 0.20 ml of urine from the patients.
The reaction was started by adding 0.10 ml of 1.02 X 10-2 M GAP and the optical
density at 340 nm was measured at 25 ± 3°C for 5 min using a Hitachi Spectro-
photometer Model 124. The inhibitory activity (%) was calculated as follows,
[(0. D. cont-O. D. test)/O. D. cont] X 100.
Determination of the molecular weight. The molecular weight of the inhibitory
substance of GAP-Dehyd was determined by gel filtration chromatography on
Biogel P-4 (column 1.5 X 82 em) using vitamin B12 (mol. wt. 1350) and CoC12 (mol.
wt. 130) as standard. 0.05 M acetic acid was used as an effluent at a flow rate of
10 ml/h, and 3 ml fractions were collected.
Purification of the GAP-Dehyd inhibitory substance. The GAP-Dehyd inhibitory
substance was extracted with ethanol (final 90%) from urine (0.5-lliter) of dia-
betics, and dried in vacuo at below 50°C. The dried residue was dissolved in
200 ml of distilled water, and then 50 g of Dowex-50 (H+ type) and 50 g of acti-
vated charcoal was added to it and stirred for 30 min at 4°C. After removing the
resin and charcoal by filtration on a glass filter (No.3), the solution was adjusted
to pH 8 by adding triethylamine and applied to a column of Dowex-l (HCOO-
type) (3x35cm). Elution was carried out at first with 300ml of 10% ethanol and
then with a linear gradient of 0-3 N formic acid containing 10% ethanol.
Thin layer chromatography. The fraction containing the inhibitory substance
obtained from the Dowex-l column was analysed by thin layer chromatography
usihg Merck precoated Kiesel Gel 60. After developing with n-butanol-acetic
acid-water (5: 3 : 5) or ethanol-acetic acid-water (90: 5 : 5) as a mobile phase, it
was sprayed with ninhydrin solution for the detection of peptides.
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RESULTS AND DISCUSSION
Inhibitory effects of GAP-Dehyd in urine samples from a normal subject
and three diabetics are shown in Fig. 1. Inhibition of GAP-Dehyd was not
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Fig. 1. Dose response of urinary inhibitory activity of GAP-
Dehyd. Urine samples (10-500 pI) from a normal and three patients
with diabetes mellitus were added to the medium for assay of GAP·
Dehyd activity and the GAP-Dehyd inhibitory activity was deter-
mined as described in the text,
observed with less than 200 ,ul of normal urine. However an appreciable inhibi-
tion of GAP-Dehyd was observed with smaller amounts of diabetic urine (W-
100 pI). The inhibition was proportional to the log dose of urine and parallel
dose response curves were obtained. Many diabetic cases showed very great
inhibitory activity of GAP-Dehyd in the urine. The mean inhibitory activity of
49 urine samples from 41 diabetic patients was 27.2±3.0% (mean±S. E. M.),
while the inhibitory activity of urine from 17 normal volunteers was 9.0 ± 1.0 %.
A significant difference of inhibitory activity was observed between normal and
diabetic urine (p<0.05). But, there were no significant correlation between the
inhibitory activity and the degrees of severity (mild, moderate and severe) of the
disease. In order to clarify the differences of the urinary concentrarion of the
inhibitory substance among the degrees of severity of the disease, further estima-
tion of the other constitutions of urine, such as the concentration of creatinine
and urea, will be required.
The molecular weight of this inhibitor was determined by gel filtration
chromatography on Biogel P-4 and confirmed to be 100-300 daltons, which is
similar to that of the nonpeptide inhibitory substance described by Schwartz and
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Turfus (2). One peak of inhibitory activity was found at the same effluent posi-
tion with CoClz (Fig. 2).
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Fig. 2. Elution pattern of GAP-Dehyd inhibitory activity from Biogel P-4. Ninety
percent ethanol extract of urine (10 ml) from a diabetics (case 3) was dried in vacuo
and dissolved in 2 ml of 0.05 M acetic acid. The solution was applied on a column of
Biogel P-4 (1.5x82 em) and eluted with the same solvent at 4°G. The effluent frac-
tions (3 ml each) were collected at a rate of 10 ml/h, and the GAP-Dehyd inhibitory
activity was determined using 100 fil of each effluent. The inhibitory activity was
observed at tube No. 30-50 of the same effluent position with GoGlz.
Furthermore, the physico-chemical property of this substance was similar to
that of the nonpeptide inhibitory substance which is adsorbed on anion exchange
resins, but different to that of the peptide inhibitor described by Bornstein et af.
(1,4). By the addition of I m of Dowex-I (CI-) or DEAE-Sephadex to I ml of
urine which had been adjusted the pH to 6-9, the inhibitory activity disappeared
completely from the supernatant, while, by the addition of Dowex-50 (H+) or
charcoal at pH 2-4, no decrease in the activity was observed.
On the other hand, GAP-Dehyd was not substantially inhibited by the
addition of 0.2 ml of creatinine solution (l mg/ml) to the reaction mixture, in-
dicating that the inhibitory substance of GAP-Dehyd in urine is not creatinine.
And it is also different from urea, because this inhibitory substance of GAP-
Dehyd had negative charge since it adsorbs to anion exchange resins.
This substance was purified by anion exchange chromatography using
Dowex-I (HCOO- type) from urinary samples exhibiting strong inhibitory activ-
ity of GAP-Dehyd, which were obtained from a patient with diabetes mellitus
and a patient of Werner's syndrome with glucose intolerance. The elution pat-
terns from the Dowex-I (HCOO-) column by gradient elution of formic acid
(0-3 N) are shown in Fig. 3. To avoid the non-specific adsorption of the inhibi-
tory substance to the resin, ethanol was added to the elution buffer to make a
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Fig. 3. Elution diagrams of inhibitory activity of GAP-Dehyd from Dowex-l
(HCeXT type) by gradient elution with 0-3 N formic acid.
90% ethanol extracts of urine (500 ml) from a patient (T. T.) of Werner's syn-
drome with glucose intolerance (al and urine (1,000 ml) from a patient (N. S.) with
diabetes (b) were applied on column of Dowex-l (HC(XT type) (1.5 x 25 cm or 3 x 45
em) and were eluted at first with 200 ml (a) or 300 ml (b) of 10% ethanol and then
eluted with 0-3 N formic acid gradient [600 ml (al or 1,000 ml (b)J containing ethanol
(IO%).
final concentration of 10%. The inhibitory substance in urine from both the
patients was similarly eluted at 0.3-0.7 N of formic acid.
The fractions I-II in Fig. 3-a and fractions III-V in Fig. 3-b were lyophy-
lized and then dissolved in 10 ml of 0.05 M acetic acid, respectively. One ml of
the each solution was applied to Merck precoated Kiesel Gel 60 for preparation.
After developing with two different solvent systems for 1-2 h, the inhibitory
substance was eluted from 1cm silicagel bands with 0.05 M acetic acid. The
inhibitory activity of GAP-Dehyd was recovered from the thin layer plates at Rf
0.4 and 0.9 (n-butanol-acetic acid-water (5: 3 : 5) and ethanol-acetic acid-water
(90: 5: 5) solvent system) corresponding to a ninhydrin reacted spot. Therefore,
the GAP-Dehyd inhibitor in urine was assumed to be a ninhydrin reactive sub-
stance of low molecular weight, which has similar physico-chemical properties
to the non-peptide inhibitory substance found in plasma by Schwartz and Turfus
(2). But, at present, it is not certain whether the inhibitory substance of GAP-
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Dehyd in urine is an identical compound to the inhibitory substance in plasma,
and further purification of both the substances is required for identification and
also for biological studies on these substances.
In this communication, we reported the presence of an inhibitory substance
of GAP-Dehyd in urine of diabetics, which may affect carbohydrate metabolism.
The elucidation of the chemical and biological properties of this GAP-Dehyd
inhibitory substance will aid in solving some important problems on the abnormal
carbohydrate metabolism in diabetes mellitus.
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